UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 97,600 shares of the healthcare conglomerate's stock after selling 6,404 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in UnitedHealth Group were worth $51,118,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Financial Management Professionals Inc. raised its holdings in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after purchasing an additional 17 shares during the last quarter. Richwood Investment Advisors LLC lifted its position in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after buying an additional 20 shares in the last quarter. Global Wealth Strategies & Associates grew its holdings in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after acquiring an additional 20 shares in the last quarter. Prentice Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock valued at $1,278,000 after acquiring an additional 21 shares in the last quarter. Finally, 44 Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 1.6% in the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after acquiring an additional 21 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

Analyst Upgrades and Downgrades

UNH has been the subject of several analyst reports. Mizuho decreased their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Barclays decreased their price objective on UnitedHealth Group to $350.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Finally, Robert W. Baird downgraded shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a research note on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $426.52.

UnitedHealth Group Trading Down 0.6%

Shares of UNH stock opened at $306.90 on Thursday. The firm has a 50 day moving average price of $370.86 and a two-hundred day moving average price of $467.96. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $278.40 billion, a PE ratio of 12.85, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the firm posted $6.91 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.88%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group's payout ratio is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.